133 related articles for article (PubMed ID: 38063281)
1. Evaluation of skin cancer screening in Germany - participation, tumor detection and interval tumors based on SHI data.
Garbe C; Augustin M; Augustin J; Baltus H; Eisemann N; Hübner J; Katalinic A; Wolf S; Hagenström K
J Dtsch Dermatol Ges; 2023 Dec; 21 Suppl 5():3-11. PubMed ID: 38063281
[TBL] [Abstract][Full Text] [Related]
2. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
3. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
5. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
6. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW
Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184
[TBL] [Abstract][Full Text] [Related]
7. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
8. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
9. [Regional differences in the health care of basal cell carcinoma].
Augustin J; Schäfer I; Thiess P; Reusch M; Augustin M
Hautarzt; 2016 Oct; 67(10):822-828. PubMed ID: 27465368
[TBL] [Abstract][Full Text] [Related]
10. [Statutory skin cancer screening in Germany : Motivation and motives for participation versus nonparticipation].
Girbig G; Augustin M; Krensel M; Andrees V
Hautarzt; 2021 Nov; 72(11):953-962. PubMed ID: 34223941
[TBL] [Abstract][Full Text] [Related]
11. Regional variations in the use of statutory skin cancer screenings in Germany: population-based spatial multisource analysis.
Augustin J; Sorbe C; Augustin M; Zander N; Kis A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1736-1743. PubMed ID: 31981431
[TBL] [Abstract][Full Text] [Related]
12. [Perception of statutory skin cancer screening in the general population : Current findings on participation, knowledge and evaluation].
Eissing L; Schäfer I; Strömer K; Kaufmann R; Enk A; Reusch M; Augustin M
Hautarzt; 2017 May; 68(5):371-376. PubMed ID: 28246676
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
14. The impossibility of mortality evaluation of skin cancer screening in Germany based on health insurance data: a case-control study.
Stang A; Schuldt K; Trocchi P; Neusser S; Speckemeier C; Pahmeier K; Wasem J; Lax H; Nonnemacher M
Eur J Cancer; 2022 Sep; 173():52-58. PubMed ID: 35863106
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer screening in Germany - perception by the public.
Augustin M; Stadler R; Reusch M; Schäfer I; Kornek T; Luger T
J Dtsch Dermatol Ges; 2012 Jan; 10(1):42-9. PubMed ID: 21923730
[TBL] [Abstract][Full Text] [Related]
16. Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspective.
Kornek T; Schäfer I; Reusch M; Blome C; Herberger K; Beikert FC; Augustin M
Dermatology; 2012; 225(4):289-93. PubMed ID: 23295723
[TBL] [Abstract][Full Text] [Related]
17. Is the quality of skin cancer screening in Germany related to the specialization of the physician who performs it?: Results of a nationwide survey among participants of skin cancer screening.
Görig T; Schneider S; Breitbart EW; Diehl K
Photodermatol Photoimmunol Photomed; 2021 Sep; 37(5):454-460. PubMed ID: 33738871
[TBL] [Abstract][Full Text] [Related]
18. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
19. The German SCREEN project--design and evaluation of the communication strategy.
Anders MP; Nolte S; Waldmann A; Capellaro M; Volkmer B; Greinert R; Breitbart EW
Eur J Public Health; 2015 Feb; 25(1):150-5. PubMed ID: 24760725
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
